Tonix Pharm Hldg (TNXP) Misses Q2 EPS by 8c

Tonix Pharm Hldg (NASDAQ: TNXP) reported Q2 EPS of ($0.61), $0.08 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Tonix Pharm Hldg (TNXP) click here.

You May Also Be Interested In

• Fox upgraded to overweight as Roku deal, ad strength lift outlook
• Allarity reports Q2 2026 results, completes stenoparib manufacturing
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94